Pierre Sujobert

Efficacy and safety of targeted therapies in VEXAS syndrome: retrospective study from the FRENVEX

Single-cell genotype-phenotype mapping identifies therapeutic vulnerabilities in VEXAS syndrome

Serious infections in patients with VEXAS syndrome: data from the French VEXAS registry

Quantitative Assessment of Vacuolization of Myeloid Precursors in VEXAS Syndrome

Clinical and pathological features of cutaneous manifestations in VEXAS syndrome: A multicenter retrospective study of 59 cases

Hematopoietic differentiation is characterized by a transient peak of entropy at a single-cell level

VEXAS: where do we stand 2 years later?

Toward a pathophysiology inspired treatment of VEXAS syndrome

Entropy as a measure of variability and stemness in single-cell transcriptomics

VEXAS syndrome-related AA amyloidosis: a case report

Standardisation of pathogenicity classification for somatic alterations in solid tumours and haematologic malignancies

Vitamin D Receptor Controls Cell Stemness in Acute Myeloid Leukemia and in Normal Bone Marrow

Deep Multi-Instance Learning Using Multi-Modal Data for Diagnosis of Lymphocytosis

Prognostic Value of Genetic Alterations in Elderly Patients with Acute Myeloid Leukemia: A Single Institution Experience

Usefulness of <scp>CD</scp>200 in the differential diagnosis of <scp>SDRPL</scp>,<scp> SMZL</scp>, and <scp>HCL</scp>

Validation of the prognostic value of the knowledge bank approach to determine AML prognosis in real life

The Genetic Basis of Hepatosplenic T-cell Lymphoma

Exome sequencing identifies recurrent <i>BCOR</i> alterations and the absence of <i>KLF2</i> , <i>TNFAIP3</i> and <i>MYD88</i> mutations in splenic diffuse red pulp small B-cell lymphoma